Skip to content
Open access

Incident versus prevalent progressive supranuclear palsy: analyses of U.S. Alzheimer’s Disease Research Centers data indicate clinical and neuropathological features of a relatively common and underrecognized tauopathy in the aging brain

Oct 2026 · Acta Neuropathologica · Vol 152 · 0 citations · 89 references
Medicine

TL;DR

In this large multicenter sample, PSP pathology was more common than other FTLD-Tau subtypes, and incident PSP often differed clinically from “classic” PSP, and PSP tau pathology was more severe overall in prevalent PSP.

Abstract

Progressive supranuclear palsy (PSP) is an adult-onset neurodegenerative disease with a heterogeneous spectrum of clinical and pathological features. The epidemiology of PSP—as defined by the gold standard of autopsy diagnosis—remains unresolved, but prevalence estimates are typically ~1:10,000. Here, we analyzed the National Alzheimer’s Coordinating Center (NACC) Neuropathology Data Set, aggregated from 38 U.S. Alzheimer’s Disease Research Centers (ADRCs). We compared clinical and neuropathologic features of autopsied participants, stratifying on cognitive status at recruitment into the cohort. The sample comprised 6845 individuals who were followed longitudinally for 4.0 (± 2.9 stdev) approximately yearly visits, n = 297 with eventual autopsy-verified PSP. Participants were not necessarily diagnosed or followed in movement disorder clinics. Among those with dementia or PSP at recruitment (n = 4310), 3.3% had corticobasal degeneration (CBD), 3.0% Pick’s disease, and 4.5% PSP pathology. Among those recruited while cognitively normal (n = 1451), 0.7% had CBD, and 0.1% Pick’s disease, while 3.2% had PSP pathology. This frequency of incident PSP pathology was higher than expected based on prior epidemiology studies. In comparing between incident (recruited normal) and prevalent (recruited with dementia or clinical PSP) cases with PSP pathology, those with incident PSP died older: 89.5 years vs 76.3 years on average. Furthermore, incident PSP pathology cases were less likely to manifest stereotypical PSP clinical features, but more likely to have parkinsonism. In a convenience sample of individuals with PSP pathology from the University of Kentucky ADRC (n = 23), digital pathology analyses using HALO software and AI-based analytic modules revealed that PSP tau pathology was more severe overall in prevalent PSP. Within the putamen, incident cases had a higher proportion of tufted astrocytes and lower proportion of NFTs. In conclusion, in this large multicenter sample, PSP pathology was more common than other FTLD-Tau subtypes, and incident PSP often differed clinically from “classic” PSP.

Read PDF

Similar papers

Open access Sep 2026

Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features

Background Having multiple comorbid neuropathologic features may confound the results of interventional trials that were designed to target a specific pathophysiologic mechanism in Alzheimer’s disease (AD) and or related dementias (ADRD). However, it is unknown what percentage of individuals undergoing AD/ADRD interven...

E. P. Coskun, Justin M. Barber, Lauren Bojarski et al. · 0 citations
Review Open access Oct 2026

A-92: Neuropsychological Profiles of Progressive Supranuclear Palsy and Parkinson’s Disease: Implications for Differential Diagnosis

Compared to PD, PSP demonstrates a more severe neuropsychological profile marked by frontal and visuospatial deficits, which can improve diagnostic accuracy, early intervention, and differential diagnosis across diverse populations.

K. Pollock, Uma Vogeti · 0 citations
Review Open access Oct 2026

A-85: Neuropsychological Features of Suspected Primary Age-related Tauopathy: A Case Study

Objective: Objective: Primary age-related tauopathy (PART) is a neuropathologic condition characterized by little to no amyloid plaques but positive medial temporal neurofibrillary degeneration (A-;T+). Approximately 20-25% of autopsy subjects over 85 years old met this criterion (Bell et al., 2019). PART is associat...

Jada Ross, Maureen Lacy · 0 citations
Open access Sep 2026

Lewy Body Disease Across Aging: Clinical and Neuropathological Correlates in a Population Brain Bank.

BACKGROUND Lewy body disease (LBD) is defined by neuronal α-synuclein pathology, but how Braak-staged LBD relates to mixed neuropathology and clinical manifestations within a single population-based cohort remains incompletely characterized. This is especially relevant in cohorts enriched for younger individuals, which...

Vitor Ribeiro Paes, Felipe L. Pereira, C. M. Silva et al. · 0 citations
Open access Oct 2026

Early caudate involvement marks a Lewy body spectrum phenotype in parkinsonism: a 5-year longitudinal study

Parkinsonian syndromes are increasingly recognized as part of a heterogeneous spectrum of Lewy body diseases, ranging from Parkinson’s disease (PD) to dementia with Lewy bodies (DLB). Identifying early markers of clinical heterogeneity remains challenging. To investigate whether striatal dopaminergic denerva...

Sara Varanese, M. P. Buongarzone, S. Viola et al. · 0 citations
Sep 2026

Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.

OBJECTIVE Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD), with significant pathological overlap between the two conditions. However, the impact of Alzheimer's co-pathology on basal forebrain (BF) atrophy and its relationship with neurodegeneration and...

Daniele Urso, Thomas Giannelli, B. Tafuri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.